Improving advanced prostate cancer care for U.S. veterans
Official title: Optimizing Advanced Prostate Cancer Care Among US Veterans
Funded at Veterans Health Administration · NIH-11145702 · Data updated 2026-11-12
This project will improve treatment access, safety, and the care experience for U.S. veterans with advanced prostate cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Veterans Health Administration NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2027 |
| Funding year | 2025 |
| NIH project number | 5I01HX003687-03 |
| Project ID | NIH-11145702 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are U.S. veterans with advanced (metastatic) prostate cancer who receive care within the VA system, especially Vietnam-era veterans, Black veterans, and those with Agent Orange exposure.
✕Less likely to help
People who are not VA patients, have early-stage prostate cancer, or receive all their care outside the VA are unlikely to get direct benefit from this project.
What this research studies
You would be part of a nationwide VA project that uses medical records and a new computer tool to identify veterans with advanced (metastatic) prostate cancer. Researchers will review treatments received, monitor safety and side effects, and compare care across groups such as Black veterans and those exposed to Agent Orange. They will also listen to veterans through interviews or surveys to learn about real-world barriers to getting guideline-recommended care. The findings will be used to design future programs to make care safer, fairer, and more personalized for veterans like you.
Why it matters
Potential benefit: If successful, this work could make prostate cancer care in the VA safer, reduce disparities, and better match treatments to veterans' needs.
How similar studies have gone: New therapies for metastatic prostate cancer have improved survival, but studies focused on delivery, equity, and patient experience are limited, and the VA's rapid NLP case-finding makes this delivery-focused approach relatively novel.
Where this research is happening
-
Veterans Health Administration
Ann Arbor, United States Active
Researchers
- Principal investigator: Caram, Megan Elizabeth Veresh — Veterans Health Administration
- Study coordinator: Caram, Megan Elizabeth Veresh
Related research
Other NIH-funded projects on the same topics.
-
Drug that blocks tumor-made male hormones and the androgen receptor for advanced prostate cancer
A new medicine aims to block both the androgen receptor and the tumor’s own production of male hormones to help men with advanced, treatment‑resistant prostate cancer.
-
Boosting a tumor-suppressing enzyme to fight advanced prostate cancer
A research grant aims to develop new molecules that enhance the PP2A enzyme to slow or stop progression of advanced prostate cancer.
-
Modulating Androgen Signals to Boost CAR T Therapy for Prostate Cancer
A new approach uses CAR T cells targeting STEAP1 to treat advanced prostate cancer, with a focus on how androgen signals affect treatment effectiveness.
-
Genomic clues to guide therapy in advanced prostate cancer
This grant looks at how a patient’s tumor and germline DNA could predict which targeted or immune therapies will work best for advanced prostate cancer.
-
DACH1-based test to predict therapy response in advanced prostate cancer
A new test using DACH1 and other markers on prostate cancer tissue aims to predict which patients will respond to therapy and guide clinical trials.
-
Understanding how doctors choose treatments to improve advanced prostate cancer care
A clinician-researcher at Duke is exploring how medical decisions are made in advanced prostate cancer to help patients get better, fairer care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.